Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

St. Jude Medical Initiates Landmark Study Of Renal Denervation For Reduction Of Heart Attack, Stroke And Death

Date: Feb-19-2013
EnligHTNment trial will evaluate whether patients with hypertension that are treated with renal denervation and medication experience additional benefits beyond a reduction in blood pressure St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced plans for a new landmark study that will evaluate whether renal denervation and medication can provide health benefits to patients beyond lowering high blood pressure...

New Research Shows 'Flutter' Of Inactivity As Americans Ignore Warning Signs Of Atrial Fibrillation

Date: Feb-19-2013
The Heart Rhythm Society Calls on all Americans to Know Risks and Warning Signs of the Most Common Arrhythmia during Heart Health Month  While the majority of Americans are at least aware of atrial fibrillation (AF), many may be unable to identify or may even ignore the warning signs of the disorder. In fact, according to a new survey issued by the Heart Rhythm Society (HRS), one in three Americans indicate that if they felt their heart quiver or skip a beat they would ignore it or wait for it to happen again before taking action...

Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent Organ Rejection In Adult Liver Transplant Patients

Date: Feb-19-2013
Zortress is the first mTOR inhibitor approved to prevent organ rejection in adult liver transplant patients in the US, where it is already approved for kidney transplantation. Under trade name Certican®, the drug was approved by European Health Authorities for use in adult liver transplant patients in the fourth quarter of 2012. Novartis have announced that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant...

New Computational Model Demonstrates How Disease Spreads In A Highly Connected World

Date: Feb-19-2013
In a world of increasing global connections, predicting the spread of infectious diseases is more complicated than ever. Pandemics no longer follow the patterns they did centuries ago, when diseases swept through populations town by town; instead, they spread quickly and seemingly at random, spurred by the interactions of 3 billion air travelers per year. A computational model developed by Northwestern University's Dirk Brockmann could provide better insight into how today's diseases might strike...

Analysis Links Ozone Levels, Cardiac Arrest

Date: Feb-19-2013
Researchers at Rice University in Houston have found a direct correlation between out-of-hospital cardiac arrests and levels of air pollution and ozone. Their work has prompted more CPR training in at-risk communities. Rice statisticians Katherine Ensor and Loren Raun announced their findings at the American Association for the Advancement of Science (AAAS) conference in Boston. Their research, based on a massive data set unique to Houston, is due to be published in the American Heart Association journal Circulation...

Spherical Nucleic Acids Have Novel Properties That Are Perfect For Biomedical Applications

Date: Feb-19-2013
Northwestern University's Chad A. Mirkin, a world-renowned leader in nanotechnology research and its application, has invented and developed a powerful material that could revolutionize biomedicine: spherical nucleic acids (SNAs). Mirkin discussed SNAs and their applications in therapeutics and diagnostics in a talk titled "Nanostructures in Biology and Medicine" at the American Association for the Advancement of Science (AAAS) annual meeting in Boston. His presentation was part of the symposium "Convergence of Physical, Engineering, and Life Sciences: Next Innovation Economy...

Designer Blood Clots Could Help Injured Soldiers On The Battlefield

Date: Feb-19-2013
When it comes to healing the terrible wounds of war, success may hinge on the first blood clot - the one that begins forming on the battlefield right after an injury. Researchers exploring the complex stream of cellular signals produced by the body in response to a traumatic injury believe the initial response - formation of a blood clot - may control subsequent healing. Using that information, they're developing new biomaterials, including artificial blood platelets laced with regulatory chemicals that could be included in an injector device the size of an iPhone...

Big Improvement Seen In Diabetes Control Over Past Decades

Date: Feb-19-2013
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention. The report, published online in Diabetes Care, shows that, from 1988 to 2010, the number of people with diabetes able to meet or exceed all three of the measures that demonstrate good diabetes management rose from about 2 percent to about 19 percent. Each measure also showed substantial improvement, with over half of people meeting each individual goal in 2010...

Promising Approaches To Prevent Latino Childhood Obesity

Date: Feb-19-2013
Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine...

Potential New Therapeutic Target For Treating Non-Small Cell Lung Cancer

Date: Feb-19-2013
Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. The study appeared in the online issue of Oncogene. The IKBKE gene is part of a family of enzyme complexes involved in increasing cellular inflammation. IKBKE overexpression has been associated with breast and prostate cancers. However, it had not been linked to environmental carcinogen, such as tobacco smoke, until now...